HitGen(SH:688222) Xin Lang Cai Jing·2025-09-10 03:05Group 1 - Chengdu Xian Dao Pharmaceutical Development Co., Ltd. experienced a decline of 5.03% on September 4, with a stock price of 27.35 yuan per share, a trading volume of 1.031 billion yuan, a turnover rate of 8.94%, and a total market capitalization of 10.959 billion yuan [1] - The company, established on February 22, 2012, and listed on April 16, 2020, is located in Chengdu Tianfu International Biological City and specializes in early-stage drug discovery services using its core DEL technology, with 99.95% of its revenue coming from new drug development services [1] Group 2 - According to data from the top ten holdings of funds, one fund under Furong Fund holds a significant position in Chengdu Xian Dao, with the Furong Medical Health Mixed Fund A (015655) holding 16,200 shares, accounting for 2.01% of the fund's net value, making it the sixth-largest holding [2] - The Furong Medical Health Mixed Fund A was established on June 28, 2022, with a latest scale of 11.8186 million, yielding a return of 14.22% this year, 10.55% over the past year, and a loss of 20.8% since inception [2]